These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19029022)

  • 21. Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.
    Pfeiffer MJ; Smit FP; Sedelaar JP; Schalken JA
    Mol Med; 2011; 17(7-8):657-64. PubMed ID: 21365123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
    Pajovic S; Corson TW; Spencer C; Dimaras H; Orlic-Milacic M; Marchong MN; To KH; Thériault B; Auspitz M; Gallie BL
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7618-24. PubMed ID: 21862643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
    Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J
    Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway.
    Zhao N; Zhou L; Lu Q; Wang S; Sun Y; Ding Y; Liu M; He H; Lang T
    Exp Eye Res; 2022 Jan; 214():108887. PubMed ID: 34890603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RB116: an RB1+ retinoblastoma cell line expressing primitive markers.
    Bejjani A; Choi MR; Cassidy L; Collins DW; O'Brien JM; Murray T; Ksander BR; Seigel GM
    Mol Vis; 2012; 18():2805-13. PubMed ID: 23233783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
    Balaji S; Santhi R; Kim U; Muthukkaruppan V; Priya CG; Vanniarajan A
    Curr Cancer Drug Targets; 2020; 20(9):710-719. PubMed ID: 32364077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low levels of ABCG2 expression in adult AML blast samples.
    Abbott BL; Colapietro AM; Barnes Y; Marini F; Andreeff M; Sorrentino BP
    Blood; 2002 Dec; 100(13):4594-601. PubMed ID: 12393637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-detection of ALDH1A1, ABCG2, ALCAM and CD133 in three A549 subpopulations at the single cell level by one-step digital RT-PCR.
    Xu Y; Hu J; Zhu Q; Song Q; Mu Y
    Integr Biol (Camb); 2018 Jun; 10(6):364-369. PubMed ID: 29808880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
    Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance of retinal cancer stem cell-like properties through long-term serum-free culture from human retinoblastoma.
    Ma B; Lei X; Guan Y; Mou LS; Yuan YF; Yue H; Lu Y; Xu GT; Qian J
    Oncol Rep; 2011 Jul; 26(1):135-43. PubMed ID: 21573498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second primary rhabdomyosarcomas in patients with bilateral retinoblastoma: a clinicopathologic and immunohistochemical study.
    Hasegawa T; Matsuno Y; Niki T; Hirohashi S; Shimoda T; Takayama J; Watanabe C; Kaneko A; Sano T; Sato M; Suzuki J
    Am J Surg Pathol; 1998 Nov; 22(11):1351-60. PubMed ID: 9808127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
    Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
    Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
    Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
    Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.
    Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y
    Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
    Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
    Schwimer CJ; Prayson RA
    Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.